Folgen
Jens Rauch
Jens Rauch
Assistant Professor and Group Leader, Systems Biology Ireland, University College Dublin
Bestätigte E-Mail-Adresse bei ucd.ie
Titel
Zitiert von
Zitiert von
Jahr
Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity
S Lee, J Rauch, W Kolch
International journal of molecular sciences 21 (3), 1102, 2020
5622020
Raf family kinases: old dogs have learned new tricks
D Matallanas, M Birtwistle, D Romano, A Zebisch, J Rauch, ...
Genes & cancer 2 (3), 232-260, 2011
4562011
Evaluating strategies to normalise biological replicates of Western blot data
A Degasperi, MR Birtwistle, N Volinsky, J Rauch, W Kolch, ...
PloS one 9 (1), e87293, 2014
2272014
The secret life of kinases: functions beyond catalysis
J Rauch, N Volinsky, D Romano, W Kolch
Cell communication and signaling 9, 1-28, 2011
2142011
Big signals from small particles: regulation of cell signaling pathways by nanoparticles
J Rauch, W Kolch, S Laurent, M Mahmoudi
Chemical reviews 113 (5), 3391-3406, 2013
1922013
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
A Shilo, VB Hur, P Denichenko, I Stein, E Pikarsky, J Rauch, W Kolch, ...
Rna 20 (4), 505-515, 2014
1142014
Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription
J Rauch, E O'Neill, B Mack, C Matthias, M Munz, W Kolch, O Gires
Cancer research 70 (4), 1679-1688, 2010
1112010
Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise
MR Birtwistle, J Rauch, A Kiyatkin, E Aksamitiene, M Dobrzyński, JB Hoek, ...
BMC systems biology 6, 1-12, 2012
962012
Allogenic antibody-mediated identification of head and neck cancer antigens
J Rauch, M Ahlemann, M Schaffrik, B Mack, S Ertongur, M Andratschke, ...
Biochemical and biophysical research communications 323 (1), 156-162, 2004
932004
Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology
O Gires, M Münz, M Schaffrik, C Kieu, J Rauch, M Ahlemann, D Eberle, ...
Cellular and Molecular Life Sciences CMLS 61, 1198-1207, 2004
872004
HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways
J Farrell, C Kelly, J Rauch, K Kida, A Garcia-Munoz, N Monsefi, ...
Journal of proteome research 13 (6), 2874-2886, 2014
792014
c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway
J Rauch, K Moran-Jones, V Albrecht, T Schwarzl, K Hunter, O Gires, ...
Cancer research 71 (13), 4664-4674, 2011
792011
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells
D Fey, D Matallanas, J Rauch, OS Rukhlenko, BN Kholodenko
Seminars in cell & developmental biology 58, 96-107, 2016
762016
CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck
O Gires, B Mack, J Rauch, C Matthias
Biochemical and biophysical research communications 343 (1), 252-259, 2006
682006
Physiological Temperature Has a Crucial Role in Amyloid Beta in the Absence and Presence of Hydrophobic and Hydrophilic Nanoparticles
M Ghavami, M Rezaei, R Ejtehadi, M Lotfi, MA Shokrgozar, B Abd Emamy, ...
ACS Chemical Neuroscience 4, 375-378, 2013
662013
Dissecting RAF inhibitor resistance by structure-based modeling reveals ways to overcome oncogenic RAS signaling
OS Rukhlenko, F Khorsand, A Krstic, J Rozanc, LG Alexopoulos, N Rauch, ...
Cell systems 7 (2), 161-179. e14, 2018
592018
Cell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticles
J Rauch, W Kolch, M Mahmoudi
Scientific reports 2 (1), 868, 2012
542012
Molecular characterization of the tumor-associated antigen AAA-TOB3
M Schaffrik, B Mack, C Matthias, J Rauch, O Gires
Cellular and Molecular Life Sciences CMLS 63, 2162-2174, 2006
392006
MultiBac: from protein complex structures to synthetic viral nanosystems
M Pelosse, H Crocker, B Gorda, P Lemaire, I Rauch, Jens and Berger
BMC Biology 15 (1), 2581, 2017
352017
SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification
J Rauch, O Gires
PROTEOMICS–Clinical Applications 2 (3), 355-371, 2008
302008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20